ArticleFrontiers in aging neuroscience2025
Protocol for detection and monitoring of post-stroke cognitive impairment through AI-powered speech analysis: a mixed methods pilot study.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Post-stroke cognitive impairment (PSCI) affects up to 75% of stroke survivors but remains challenging to detect with traditional neuropsychological assessments. Recent advances in artificial intelligence and natural language processing have opened new avenues for cognitive screening through speech analysis, yet their application to PSCI remains largely unexplored. This study aims to characterize speech markers of PSCI in the first-year post-stroke and evaluate their utility for predicting cognitive outcomes in a Singapore cohort. Methods: This prospective mixed-methods study will recruit 30 stroke survivors from the Alexandra Hospital and National University Hospital in Singapore. Participants will be assessed at four timepoints: baseline (within 6 weeks of stroke onset), 3-, 6-, and 12-months post-stroke. At each visit, participants will complete the Montreal Cognitive Assessment (MoCA) and a standardized speech protocol comprising picture description and semi-structured conversation tasks. Speech recordings will be automatically transcribed using automated speech recognition (ASR) systems based on pretrained acoustic models, and comprehensive linguistic and acoustic features will be extracted. Machine learning models will be developed to predict MoCA-defined cognitive impairment. Statistical analysis will include correlation analysis between speech features and MoCA scores, as well as machine learning classification and regression models to predict cognitive impairment. Linear mixed-effects models will characterize trajectories of MoCA scores and speech features over time. Qualitative analysis will follow an inductive thematic approach to explore acceptability and usability of speech-based screening. Discussion: This study represents a critical step toward developing speech-based digital biomarkers for PSCI detection that are sensitive, culturally appropriate, and clinically feasible. If validated, this approach could transform current models of PSCI care by enabling remote, frequent, and naturalistic monitoring of cognitive health, potentially improving outcomes through earlier intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.